Human Papillomavirus-DNA Loads in Actinic Keratoses Exceed Those in Non-melanoma Skin Cancers

2006 ◽  
Vol 2006 ◽  
pp. 271
Author(s):  
B.H. Thiers
2005 ◽  
Vol 125 (1) ◽  
pp. 93-97 ◽  
Author(s):  
Soenke Jan Weissenborn ◽  
Ingo Nindl ◽  
Karin Purdie ◽  
Catherine Harwood ◽  
Charlotte Proby ◽  
...  

1998 ◽  
Vol 111 (1) ◽  
pp. 123-127 ◽  
Author(s):  
Catherine A. Harwood ◽  
Patricia J. Spink ◽  
T. Surentheran ◽  
Irene M. Leigh ◽  
John L.M. Hawke ◽  
...  

2009 ◽  
Vol 46 ◽  
pp. S43
Author(s):  
O. Keseroglu ◽  
N. Ilter ◽  
G. Bozdayi ◽  
S. Rota

Pathogens ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 262
Author(s):  
Alessandro Medda ◽  
Daria Duca ◽  
Susanna Chiocca

The Human Papillomavirus (HPV) is the causative agent of different kinds of tumors, including cervical cancers, non-melanoma skin cancers, anogenital cancers, and head and neck cancers. Despite the vaccination campaigns implemented over the last decades, we are far from eradicating HPV-driven malignancies. Moreover, the lack of targeted therapies to tackle HPV-related tumors exacerbates this problem. Biomarkers for early detection of the pathology and more tailored therapeutic approaches are needed, and a complete understanding of HPV-driven tumorigenesis is essential to reach this goal. In this review, we overview the molecular pathways implicated in HPV infection and carcinogenesis, emphasizing the potential targets for new therapeutic strategies as well as new biomarkers.


2003 ◽  
Vol 295 (7) ◽  
pp. 273-279 ◽  
Author(s):  
Herbert Pfister ◽  
Pawel G. Fuchs ◽  
Slawomir Majewski ◽  
Stefania Jablonska ◽  
Iwona Pniewska ◽  
...  

2000 ◽  
Vol 161 (1) ◽  
pp. 83-88 ◽  
Author(s):  
K.A Biliris ◽  
E Koumantakis ◽  
D.N Dokianakis ◽  
G Sourvinos ◽  
D.A Spandidos

Sign in / Sign up

Export Citation Format

Share Document